Conjunctival Melanoma: Current Treatments and Future Options.
Grimes JM, Shah NV, Samie FH, Carvajal RD, Marr BP.
Am J Clin Dermatol. 2020 Jun;21(3):371-381. doi: 10.1007/s40257-019-00500-3.
Conjunctival Melanoma - Epidemiological Trends and Features.
Kaštelan S, Gverović Antunica A, Beketić Orešković L, Salopek Rabatić J, Kasun B, Bakija I.
Pathol Oncol Res. 2018 Oct;24(4):787-796. doi: 10.1007/s12253-018-0419-3. Epub 2018 May 25.
Conjunctival melanoma.
Jakobiec FA.
Arch Ophthalmol. 1980 Aug;98(8):1378-84. doi: 10.1001/archopht.1980.01020040230003.
Current Management of Conjunctival Melanoma Part 1: Clinical Features, Diagnosis and Histopathology.
Koç İ, Kıratlı H.
Turk J Ophthalmol. 2020 Oct 30;50(5):293-303. doi: 10.4274/tjo.galenos.2020.38096.
Conjunctival melanoma: pitfalls and dilemmas in management.
Shildkrot Y, Wilson MW.
Curr Opin Ophthalmol. 2010 Sep;21(5):380-6. doi: 10.1097/ICU.0b013e32833b7aab.
Advances in the management of conjunctival melanoma.
Vora GK, Demirci H, Marr B, Mruthyunjaya P.
Surv Ophthalmol. 2017 Jan-Feb;62(1):26-42. doi: 10.1016/j.survophthal.2016.06.001. Epub 2016 Jun 16.
Clinical treatment options for early-stage and advanced conjunctival melanoma.
Zeng Y, Hu C, Shu L, Pan Y, Zhao L, Pu X, Wu F.
Surv Ophthalmol. 2021 May-Jun;66(3):461-470. doi: 10.1016/j.survophthal.2020.09.004. Epub 2020 Sep 25.
Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Colby KA, Nagel DS.
Cornea. 2005 Apr;24(3):352-5. doi: 10.1097/01.ico.0000141229.18472.a2.
Biological characteristics and clinical management of uveal and conjunctival melanoma.
Kaštelan S, Pavičić AD, Pašalić D, Nikuševa-Martić T, Čanović S, Kovačević P, Konjevoda S.
Oncol Res. 2024 Jul 17;32(8):1265-1285. doi: 10.32604/or.2024.048437. eCollection 2024.
Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P, Huerva V.
Surv Ophthalmol. 2022 Sep-Oct;67(5):1391-1404. doi: 10.1016/j.survophthal.2022.03.003. Epub 2022 Mar 9.
